JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floreani, M.
Right arrow Articles by Bellin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floreani, M.
Right arrow Articles by Bellin, S.

Mechanisms of plumbagin action on guinea pig isolated atria

M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin

Department of Pharmacology, University of Padova, Italy.

In electrically driven guinea pig left atria, plumbagin (5-hydroxy-2- methyl-1,4-naphthoquinone; 0.5-10 microM) produced a marked positive inotropic effect that was about 65% that caused by isoprenaline in the same experimental conditions. The effect was mainly not dependent on catecholamine release from adrenergic stores. An EC50 of 3 microM was calculated from the concentration-response curves. The increase in force of contraction was followed by a nonreversible contracture. Plumbagin was reduced by cardiac mitochondrial and soluble reductases with consequent generation of large amounts of superoxide anion. The assay of reduced glutathione/oxidized glutathione content in atria, treated with 10 microM plumbagin and frozen at the appearance of increase in diastolic tension, showed a significant decrease in reduced glutathione (-52% with respect to control atria) and a 5-fold increase in oxidized glutathione levels. Moreover, in the same experimental conditions a significant decrease in adenosine triphosphate (-55% with respect to the controls) and in adenylate energy charge (from 0.92- 0.64) was observed. Of the enzymes and transport systems involved in the control of the cardiac contractility, the sarcoplasmic reticulum Ca2+ pump seemed to be a specific target for plumbagin. After 30 min of incubation with cardiac sarcoplasmic reticulum membrane vesicles, plumbagin inhibited Ca2+ uptake by the pump in a concentration- dependent manner (IC50 = 3 microM). On the basis of these results, the increase in diastolic tension caused by plumbagin appears to be related to intracellular Ca2+ accumulation, due both to the low availability of adenosine triphosphate for ionic pumps and direct inhibition of Ca2+ reuptake in sarcoplasmic reticulum.

Volume 278, Issue 2, pp. 763-770, 08/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
V. M. Bulatovic, N. L. Wengenack, J. R. Uhl, L. Hall, G. D. Roberts, F. R. Cockerill III, and F. Rusnak
Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2765 - 2771.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. A. Zoeller, T. J. Grazia, P. LaCamera, J. Park, D. P. Gaposchkin, and H. W. Farber
Increasing plasmalogen levels protects human endothelial cells during hypoxia
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H671 - H679.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Dorigo, M. Floreani, G. Santostasi, I. Maragno, D. Danieli-Betto, E. Germinario, S. M. Magno, G. Primofiore, A. M. Marini, and F. Da Settimo
Pharmacological Characterization of a New Ca2+ Sensitizer
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 994 - 1004.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Floreani, P. A. Borea, S. Gessi, L. Mosti, P. Fossa, and P. Dorigo
A New Milrinone Analog: Role of Binding to A1 Adenosine Receptor in its Positive Inotropic Effect on Isolated Guinea Pig and Rat Atria
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 541 - 547.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.